MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study

Augusto LF Marino, Adriane Feijó Evangelista, René AC Vieira, Taciane Macedo, Lígia Maria Kerr, Lucas Faria Abrahão‐Machado, Adhemar Longatto‐Filho, Henrique C.S. Silveira, Márcia Maria Chiquitelli Marques

BMC Cancer · 2014 · 47 citations · 42 references

DOIFull text

Open access

Abstract

Women with metastatic breast cancer, especially CSII, presented up-regulated levels of miR-183, miR-494 and miR-21, which were associated with a poor prognosis. These miRNAs therefore represent new risk biomarkers of breast cancer metastasis and may be useful for future targeted therapies.

References

42